Inventor · disambiguated record
Mariappan V. Chelliah
Also filed as: CHELLIAH MARIAPPAN · CHELLIAH MARIAPPAN V
19 granted patents·6 pending applications·242 citations·filing 2001–2013
93Inventor score
Files withSCHERING CORP14CHACKALAMANNIL SAMUEL3MERCK SHARP & DOHME3CHELLIAH MARIAPPAN V1CLASBY MARTIN C1
Top patents by PatentIndex Score
25 records- 0196US6645987B2Nor-seco himbacine derivatives useful as thrombin receptor antagonistsSCHERING CORP·Filed 2001·Granted Nov 11, 2003·97 cites·14 claims
- 0292US7037920B2Substituted tricyclic himbacine derivatives that are useful as thrombin receptor antagonistsSCHERING CORP·Filed 2002·Granted May 2, 2006·52 cites·15 claims
- 0391US7776889B2Spirocyclic thrombin receptor antagonistsSCHERING CORP·Filed 2006·Granted Aug 17, 2010·20 cites·8 claims
- 0488US6894065B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted May 17, 2005·31 cites·16 claims
- 0586US7713999B2Thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted May 11, 2010·8 cites·46 claims
- 0684US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 0781US8022088B2Substituted bicyclic and tricyclic thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted Sep 20, 2011·5 cites·10 claims
- 0880US7488752B2Thrombin receptor antagonistsSCHERING CORP·Filed 2005·Granted Feb 10, 2009·6 cites·25 claims
- 0979US7442712B2Constrained himbacine analogs as thrombin receptor antagonistsSCHERING CORP·Filed 2005·Granted Oct 28, 2008·6 cites·15 claims
- 1074US7488742B2Thrombin receptor antagonistsSCHERING CORP·Filed 2003·Granted Feb 10, 2009·5 cites·15 claims
- 1169US8153664B2Bicyclic and tricyclic derivatives as thrombin receptor antagonistsCHACKALAMANNIL SAMUEL·Filed 2007·Granted Apr 10, 2012·1 cites·6 claims
- 1263US8609676B24, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitorsCHELLIAH MARIAPPAN V·Filed 2010·Granted Dec 17, 2013·1 cites·12 claims
- 1363US8148363B2Heterocyclic compounds as factor IXA inhibitorsCLASBY MARTIN C·Filed 2009·Granted Apr 3, 2012·1 cites·4 claims
- 1463US2009069383A1Thrombin Receptor AntagonistsSCHERING CORP·Filed 2008·Application pending·0 cites
- 1563US2009076088A1Thrombin Receptor AntagonistsSCHERING CORP·Filed 2008·Application pending·0 cites
- 1659US2007270439A1Thrombin receptor antagonistsSCHERING CORP·Filed 2007·Application pending·0 cites
- 1751US2006106050A1Thrombin receptor antagonistsSCHERING CORP·Filed 2005·Application pending·0 cites
- 1849US8642582B2Morpholinone compounds as factor IXa inhibitorsNISHIDA HIDEMITSU·Filed 2009·Granted Feb 4, 2014·0 cites·19 claims
- 1949US8372980B2Fused ring thrombin receptor antagonistsMERCK SHARP & DOHME·Filed 2011·Granted Feb 12, 2013·0 cites·11 claims
- 2047US7888377B2Monocyclic and bicyclic himbacine derivatives useful as thrombin receptor antagonistsSCHERING CORP·Filed 2007·Granted Feb 15, 2011·0 cites·27 claims
- 2145US7897601B2Cannabinoid receptor modulatorsINTERVET INC·Filed 2007·Granted Mar 1, 2011·0 cites·67 claims
- 2243US2012157403A1Bicyclic and tricyclic derivatives as thrombin receptor antagonistsCHACKALAMANNIL SAMUEL·Filed 2012·Application pending·0 cites
- 2342US9708270B2Substituted spiropiperidinyl compounds useful as GPR120 agonistsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·10 claims
- 2440US2004192753A1Methods of use of thrombin receptor antagonistsFiled 2003·Application pending·0 cites
- 2535US8987242B2Morpholinone compounds as factor IXA inhibitorsCHACKALAMANNIL SAMUEL·Filed 2010·Granted Mar 24, 2015·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →